CompletedNot applicableNCT01576003

Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants

Studying Short bowel syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Conrad R Cole, MD
Children's Hospital Medical Center, Cincinnati
Intervention
Glutamine(drug)
Enrollment
10 enrolled
Eligibility
All sexes
Timeline
2012 – 2015

Study locations (2)

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Emmaus Medical, Inc. · University of Michigan · Emory University · University of Colorado, Denver

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01576003 on ClinicalTrials.gov

Other trials for Short bowel syndrome

Additional recruiting or active studies for the same condition.

See all trials for Short bowel syndrome →

← Back to all trials